Internal Medicine, Medical Oncology · Tampa, FL
NPI
1487740551
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (813) 745-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
323 services
Medicare patients, 2024
152
Average age 73
Drug cost, 2024
$1.3M
261 prescriptions
Company payments, 2024
$17.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles Lu was code 99215 (office e&m - established), 209 times for 96 patients. In total Charles Lu billed 323 services in 14 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 209 | 96 | $100.39 | $21K |
| 99205 Office E&M - New | Facility | 41 | 41 | $137.11 | $5,621 |
| 99214 Office E&M - Established | Facility | 16 | 15 | $67.60 | $1,082 |
| 99442 Telephone Services | Office | 16 | 11 | $62.23 | $996 |
By year: 2022 $57K for 545 services; 2023 $49K for 484 services; 2024 $31K for 323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles Lu prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 42 prescriptions and refills. In total Charles Lu wrote 261 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 42 | 42 | Under 11 | $724K |
| Ondansetron Hcl Generic | 36 | 36 | 28 | $464 |
| Levothyroxine Sodium Generic | 29 | 45 | Under 11 | $230 |
| Lorbrena Lorlatinib | 21 | 23 | Under 11 | $473K |
| Dexamethasone Generic | 19 | 19 | 16 | $215 |
| Prochlorperazine Maleate Generic | 19 | 19 | 17 | $231 |
| Alecensa Alectinib Hcl | 16 | 16 | Under 11 | $49K |
Brand drugs: 115 claims; generic drugs: 146 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Charles Lu $17.8 ($17.8 in general payments such as food, travel and fees) from 1 company. The largest payer was SpringWorks Therapeutics, Inc. with $17.8.
| Company | Payments | Amount |
|---|---|---|
| SpringWorks Therapeutics, Inc. | 1 | $17.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.